Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00301730 · ClinicalTrials.gov registry record · Phase 1

Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung

A Phase 1 study of Breast Cancer and Metastatic Cancer, sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 1
Development phase
1
Enrollment target
1
Study location

NCT00301730 is a Phase 1 study of Breast Cancer and Metastatic Cancer that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00301730, a Phase 1 study of Breast Cancer and Metastatic Cancer, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 1
Development phase
1 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Biological therapy, such as cellular adoptive immunotherapy, may stimulate the immune system in different ways and stop tumor cells from growing. PURPOSE: This phase I trial is studying how well cellular adoptive immunotherapy works in treating a patient who has undergone a donor stem cell transplant for breast cancer that has spread to the lung.

Conditions Studied

Breast Cancer Metastatic Cancer

Interventions

  • DRUG paclitaxel
  • BIOLOGICAL trastuzumab
  • PROCEDURE conventional surgery
  • BIOLOGICAL aldesleukin
  • BIOLOGICAL therapeutic tumor infiltrating lymphocytes

Study Locations (1)

Maryland

  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support - Bethesda

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2005-10
Phase Phase 1

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00301730

The ClinicalTrials.gov registry entry for NCT00301730 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which paclitaxel is the first listed.

NCT00301730 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00301730 about?

NCT00301730 is a clinical study titled "Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung". RATIONALE: Biological therapy, such as cellular adoptive immunotherapy, may stimulate the immune system in different ways and stop tumor cells from growing. PURPOSE: This phase I trial is studying how well cellular adoptive immunotherapy works in treating a patient who has undergone a donor stem ce...

What is the current status of trial NCT00301730?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2005-10.

What conditions does trial NCT00301730 study?

This clinical trial studies the following conditions: Breast Cancer, Metastatic Cancer.

What interventions are being tested in trial NCT00301730?

The interventions under investigation include: paclitaxel (DRUG), trastuzumab (BIOLOGICAL), conventional surgery (PROCEDURE), aldesleukin (BIOLOGICAL), therapeutic tumor infiltrating lymphocytes (BIOLOGICAL).

Who is sponsoring clinical trial NCT00301730?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00301730 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Metastatic Cancer

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.